- Home
- SANG vs NVCT Comparison
SANG vs NVCT Comparison
Compare SANG & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SANG
- NVCT
- Stock Information
- Founded
- SANG 1984
- NVCT 2020
- Country
- SANG Canada
- NVCT United States
- Employees
- SANG N/A
- NVCT N/A
- Industry
- SANG Computer Software: Programming Data Processing
- NVCT Medicinal Chemicals and Botanical Products
- Sector
- SANG Technology
- NVCT Health Care
- Exchange
- SANG Nasdaq
- NVCT Nasdaq
- Market Cap
- SANG 189.6M
- NVCT 184.9M
- IPO Year
- SANG 2021
- NVCT 2022
- Fundamental
- Price
- SANG $5.74
- NVCT $7.74
- Analyst Decision
- SANG
- NVCT Strong Buy
- Analyst Count
- SANG 0
- NVCT 3
- Target Price
- SANG N/A
- NVCT $17.00
- AVG Volume (30 Days)
- SANG 4.8K
- NVCT 93.8K
- Earning Date
- SANG 05-08-2025
- NVCT 08-05-2025
- Dividend Yield
- SANG N/A
- NVCT N/A
- EPS Growth
- SANG N/A
- NVCT N/A
- EPS
- SANG N/A
- NVCT N/A
- Revenue
- SANG $238,264,000.00
- NVCT N/A
- Revenue This Year
- SANG N/A
- NVCT N/A
- Revenue Next Year
- SANG $2.91
- NVCT N/A
- P/E Ratio
- SANG N/A
- NVCT N/A
- Revenue Growth
- SANG N/A
- NVCT N/A
- 52 Week Low
- SANG $4.08
- NVCT $4.44
- 52 Week High
- SANG $7.99
- NVCT $11.80
- Technical
- Relative Strength Index (RSI)
- SANG 52.55
- NVCT 32.93
- Support Level
- SANG $5.55
- NVCT $7.84
- Resistance Level
- SANG $5.96
- NVCT $8.28
- Average True Range (ATR)
- SANG 0.14
- NVCT 0.46
- MACD
- SANG -0.02
- NVCT -0.10
- Stochastic Oscillator
- SANG 56.00
- NVCT 1.27
About SANG Sangoma Technologies Corporation
Sangoma Technologies Corp is a provider of hardware and software components that enable or enhance Internet Protocol Communications Systems for both telecom and datacom applications. It is engaged in the development, manufacturing, distribution, and support of voice and data connectivity components for software-based communication applications. Its product includes data and telecom boards for media and signal processing, as well as gateway appliances and software. The Company sells into two geographic centers: USA and Other countries. Key revenue is generated from USA.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.